← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

Name Funds
holding
Growth Growth % Fund
value
AUTL icon
51
Autolus Therapeutics
AUTL
$458M
66 -1 -1% $106M
CERO icon
52
DELISTED
CERo Therapeutics
CERO
65 +13 +25% $153M
AKUS
53
DELISTED
Akouos Inc
AKUS
64 -2 -3% $241M
FBIO icon
54
Fortress Biotech
FBIO
$63.7M
64 -2 -3% $25.8M
GMDA
55
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
62 +5 +9% $38.3M
RUBY
56
DELISTED
Rubius Therapeutics, Inc
RUBY
62 -10 -14% $29.7M
SLDB icon
57
Solid Biosciences
SLDB
$615M
58 -9 -13% $33.4M
CABA icon
58
Cabaletta Bio
CABA
$263M
54 -1 -2% $7.76M
IMTX icon
59
Immatics
IMTX
$1.09B
54 +5 +10% $221M
IPSC icon
60
Century Therapeutics
IPSC
$272M
54 -2 -4% $209M
TSHA icon
61
Taysha Gene Therapies
TSHA
$1.22B
54 -5 -8% $27M
NKGN icon
62
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
53 +6 +13% $143M
NGNE icon
63
Neurogene
NGNE
$479M
52 -11 -17% $12M
CLLS icon
64
Cellectis
CLLS
$111M
49 +5 +11% $23.6M
SQZ
65
DELISTED
SQZ Biotechnologies Company
SQZ
48 -5 -9% $33.5M
ORTX
66
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
47 -3 -6% $24.7M
AGTC
67
DELISTED
Applied Genetic Technologies Corporation
AGTC
45 -2 -4% $3.34M
MRKR icon
68
Marker Therapeutics
MRKR
$15.3M
45 -3 -6% $7.56M
ATHX
69
DELISTED
Athersys, Inc. Common Stock
ATHX
44 -71 -62% $4.11M
BCLI icon
70
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
42 -6 -13% $17.1M
LNAI icon
71
Lunai Bioworks
LNAI
$3.74M
42 -9 -18% $6.87M
DBTX
72
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
40 -2 -5% $62.1M
SIOX
73
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
40 -1 -2% $7.62M
LOGC
74
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
39 -8 -17% $2.82M
IRD icon
75
Opus Genetics
IRD
$337M
37 -1 -3% $5.69M